Wellbutrin XL Paragraph IV Filing
This article was originally published in The Pink Sheet Daily
Executive Summary
The first ANDA with a Paragraph IV certification for GlaxoSmithKline's Wellbutrin XL was filed Sept. 21, according to FDA's Nov. 17 update of Paragraph IV filings